Goldman Sachs’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.1M | Buy |
608,800
+368,800
| +154% | +$9.82M | ﹤0.01% | 2582 |
|
|
2025
Q4 | $5.98M | Sell |
240,000
-348,300
| -59% | -$8.78M | ﹤0.01% | 3587 |
|
|
2025
Q3 | $15M | Buy |
588,300
+438,300
| +292% | +$10.8M | ﹤0.01% | 2556 |
|
|
2025
Q2 | $3.64M | Sell |
150,000
-100,000
| -40% | -$2.33M | ﹤0.01% | 3709 |
|
|
2025
Q1 | $6.33M | Sell |
250,000
-176,000
| -41% | -$4.61M | ﹤0.01% | 3126 |
|
|
2024
Q4 | $11.3M | Sell |
426,000
-408,500
| -49% | -$11.1M | ﹤0.01% | 2675 |
|
|
2024
Q3 | $24.2M | Buy |
834,500
+430,000
| +106% | +$12.5M | ﹤0.01% | 1894 |
|
|
2024
Q2 | $11.3M | Sell |
404,500
-82,000
| -17% | -$2.26M | ﹤0.01% | 2383 |
|
|
2024
Q1 | $13.5M | Sell |
486,500
-958,200
| -66% | -$26.6M | ﹤0.01% | 2187 |
|
|
2023
Q4 | $41.6M | Buy |
1,444,700
+766,500
| +113% | +$23.2M | 0.01% | 1309 |
|
|
2023
Q3 | $22.5M | Sell |
678,200
-129,500
| -16% | -$4.58M | ﹤0.01% | 1691 |
|
|
2023
Q2 | $29.6M | Buy |
807,700
+82,000
| +11% | +$3.19M | 0.01% | 1518 |
|
|
2023
Q1 | $29.6M | Sell |
725,700
-1,129,100
| -61% | -$48.8M | 0.01% | 1456 |
|
|
2022
Q4 | $95M | Sell |
1,854,800
-98,100
| -5% | -$4.7M | 0.02% | 745 |
|
|
2022
Q3 | $85.5M | Buy |
1,952,900
+18,400
| +1% | +$894K | 0.02% | 770 |
|
|
2022
Q2 | $101M | Sell |
1,934,500
-104,800
| -5% | -$5.34M | 0.03% | 668 |
|
|
2022
Q1 | $106M | Sell |
2,039,300
-151,100
| -7% | -$7.84M | 0.02% | 731 |
|
|
2021
Q4 | $129M | Sell |
2,190,400
-35,600
| -2% | -$1.76M | 0.03% | 665 |
|
|
2021
Q3 | $95.7M | Buy |
2,226,000
+91,600
| +4% | +$4.06M | 0.02% | 777 |
|
|
2021
Q2 | $83.6M | Buy |
2,134,400
+870,300
| +69% | +$33.8M | 0.02% | 852 |
|
|
2021
Q1 | $45.8M | Buy |
1,264,100
+906,600
| +254% | +$32.2M | 0.01% | 1235 |
|
|
2020
Q4 | $13.2M | Buy |
357,500
+121,720
| +52% | +$4.46M | ﹤0.01% | 2231 |
|
|
2020
Q3 | $8.21M | Buy |
+235,780
| New | +$8.27M | ﹤0.01% | 2495 |
|
|
2020
Q1 | – | Sell |
-118,997
| Closed | -$4.42M | – | 5471 |
|
|
2019
Q4 | $4.42M | Hold |
118,997
| – | – | ﹤0.01% | 3056 |
|
|
2019
Q3 | $4.06M | Sell |
118,997
-3,134,701
| -96% | -$114M | ﹤0.01% | 3020 |
|
|
2019
Q2 | $134M | Buy |
3,253,698
+2,583,881
| +386% | +$103M | 0.04% | 526 |
|
|
2019
Q1 | $27M | Sell |
669,817
-555,247
| -45% | -$22.2M | 0.01% | 1614 |
|
|
2018
Q4 | $50.7M | Buy |
1,225,064
+672,136
| +122% | +$27.9M | 0.02% | 1081 |
|
|
2018
Q3 | $23.1M | Buy |
552,928
+13,069
| +2% | +$503K | 0.01% | 1816 |
|
|
2018
Q2 | $18.6M | Sell |
539,859
-238,836
| -31% | -$8.16M | 0.01% | 1932 |
|
|
2018
Q1 | $26.2M | Sell |
778,695
-466,501
| -37% | -$16M | 0.01% | 1630 |
|
|
2017
Q4 | $42.8M | Sell |
1,245,196
-477,462
| -28% | -$16.3M | 0.01% | 1405 |
|
|
2017
Q3 | $58.3M | Sell |
1,722,658
-1,907,423
| -53% | -$61.3M | 0.01% | 1167 |
|
|
2017
Q2 | $116M | Buy |
3,630,081
+1,068,229
| +42% | +$33.7M | 0.03% | 677 |
|
|
2017
Q1 | $83.2M | Sell |
2,561,852
-2,486,492
| -49% | -$78.4M | 0.02% | 880 |
|
|
2016
Q4 | $156M | Buy |
5,048,344
+1,733,619
| +52% | +$52.9M | 0.04% | 510 |
|
|
2016
Q3 | $107M | Sell |
3,314,725
-1,205,143
| -27% | -$40.3M | 0.03% | 676 |
|
|
2016
Q2 | $151M | Sell |
4,519,868
-931,525
| -17% | -$29.7M | 0.05% | 457 |
|
|
2016
Q1 | $153M | Buy |
5,451,393
+3,016,653
| +124% | +$86.2M | 0.05% | 453 |
|
|
2015
Q4 | $74.6M | Sell |
2,434,740
-2,033,377
| -46% | -$64M | 0.02% | 840 |
|
|
2015
Q3 | $133M | Buy |
4,468,117
+1,765,239
| +65% | +$56.6M | 0.04% | 478 |
|
|
2015
Q2 | $86M | Sell |
2,702,878
-5,028,423
| -65% | -$164M | 0.03% | 760 |
|
|
2015
Q1 | $255M | Buy |
7,731,301
+5,522,644
| +250% | +$176M | 0.08% | 262 |
|
|
2014
Q4 | $65.3M | Buy |
2,208,657
+634,192
| +40% | +$18.2M | 0.02% | 917 |
|
|
2014
Q3 | $44.2M | Buy |
1,574,465
+4,637
| +0.3% | +$130K | 0.01% | 1166 |
|
|
2014
Q2 | $44.2M | Sell |
1,569,828
-2,388,891
| -60% | -$68.1M | 0.01% | 1196 |
|
|
2014
Q1 | $121M | Buy |
3,958,719
+330,113
| +9% | +$9.84M | 0.04% | 538 |
|
|
2013
Q4 | $105M | Sell |
3,628,606
-697,221
| -16% | -$20.3M | 0.03% | 609 |
|
|
2013
Q3 | $118M | Sell |
4,325,827
-1,121,245
| -21% | -$30.5M | 0.04% | 523 |
|
|
2013
Q2 | $145M | Buy |
+5,447,072
| New | +$151M | 0.06% | 392 |
|
Other funds holding PFE
VCM
VPM
Goldman Sachs's PFE Position: Q1 2026 in Review
Goldman Sachs increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $188M and bringing the position to 47,105,556 shares worth $1.32B. The position accounts for 0.15% of the portfolio, ranked #113.
Goldman Sachs first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.14B in Q1 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Goldman Sachs held 47,105,556 shares of Pfizer worth $1.32B as of Q1 2026.
- Goldman Sachs bought 7,049,994 Pfizer shares in Q1 2026, an estimated $188M.
- Pfizer made up 0.15% of Goldman Sachs's portfolio in Q1 2026, its #113 holding.
- Goldman Sachs first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Pfizer position peaked at $3.14B in Q1 2016.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.